BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37019333)

  • 21. Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy.
    Ramchand J; Wallis M; Macciocca I; Lynch E; Farouque O; Martyn M; Phelan D; Chong B; Lockwood S; Weintraub R; Thompson T; Trainer A; Zentner D; Vohra J; Chetrit M; Hare DL; James P
    J Am Heart Assoc; 2020 Jan; 9(2):e013346. PubMed ID: 31931689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.
    Harris E; Topf A; Barresi R; Hudson J; Powell H; Tellez J; Hicks D; Porter A; Bertoli M; Evangelista T; Marini-Betollo C; Magnússon Ó; Lek M; MacArthur D; Bushby K; Lochmüller H; Straub V
    Orphanet J Rare Dis; 2017 Sep; 12(1):151. PubMed ID: 28877744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service.
    Westra D; Schouten MI; Stunnenberg BC; Kusters B; Saris CGJ; Erasmus CE; van Engelen BG; Bulk S; Verschuuren-Bemelmans CC; Gerkes EH; de Geus C; van der Zwaag PA; Chan S; Chung B; Barge-Schaapveld DQCM; Kriek M; Sznajer Y; van Spaendonck-Zwarts K; van der Kooi AJ; Krause A; Schönewolf-Greulich B; de Die-Smulders C; Sallevelt SCEH; Krapels IPC; Rasmussen M; Maystadt I; Kievit AJA; Witting N; Pennings M; Meijer R; Gillissen C; Kamsteeg EJ; Voermans NC
    J Neuromuscul Dis; 2019; 6(2):241-258. PubMed ID: 31127727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.
    Abicht A; Scharf F; Kleinle S; Schön U; Holinski-Feder E; Horvath R; Benet-Pagès A; Diebold I
    Mol Genet Genomic Med; 2018 Nov; 6(6):1188-1198. PubMed ID: 30406974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
    Karacan İ; Balamir A; Uğurlu S; Aydın AK; Everest E; Zor S; Önen MÖ; Daşdemir S; Özkaya O; Sözeri B; Tufan A; Yıldırım DG; Yüksel S; Ayaz NA; Ömeroğlu RE; Öztürk K; Çakan M; Söylemezoğlu O; Şahin S; Barut K; Adroviç A; Seyahi E; Özdoğan H; Kasapçopur Ö; Turanlı ET
    Rheumatol Int; 2019 May; 39(5):911-919. PubMed ID: 30783801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted gene panel provides advantages over whole-exome sequencing for diagnosing obesity and diabetes mellitus.
    Yu H; Yu H; Zhang R; Peng D; Yan D; Gu Y; Bao Y; Jia W; Zhang H; Hu C
    J Mol Cell Biol; 2023 Nov; 15(6):. PubMed ID: 37327085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-exome sequencing for genetic diagnosis of idiopathic liver injury in children.
    Lülecioğlu AA; Yazıcı YY; Baran A; Warasnhe K; Beyaz Ş; Aytekin C; Özçay F; Aydemir Y; Barış Z; Belkaya S
    J Cell Mol Med; 2024 Jun; 28(11):e18485. PubMed ID: 38864694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Gene Sanger Sequencing Should Remain the First-Tier Genetic Test for Children Suspected to Have the Five Common X-Linked Inborn Errors of Immunity.
    Chan KW; Wong CY; Leung D; Yang X; Fok SFS; Mak PHS; Yao L; Ma W; Mao H; Zhao X; Liang W; Singh S; Barbouche MR; He JX; Jiang LP; Liew WK; Le MHT; Muktiarti D; Santos-Ocampo FJ; Djidjik R; Belaid B; Ismail IH; Abdul Latiff AH; Lee WS; Chen TX; Liu J; Jin R; Wang X; Chien YH; Yu HH; Raj D; Raj R; Vaughan J; Urban M; van den Berg S; Eley B; Lee AC; Isa MS; Ang EY; Lee BW; Yeoh AEJ; Shek LP; Quynh Le NN; Nguyen VAT; Phan Nguyen Lien A; Capulong RD; Mallillin JM; Villanueva JCMM; Camonayan KAB; Vera M; Casis-Hao RJ; Lobo RCM; Foronda R; Binas VWE; Boushaki S; Kechout N; Phongsamart G; Wongwaree S; Jiratchaya C; Lao-Araya M; Trakultivakorn M; Suratannon N; Jirapongsananuruk O; Chantveerawong T; Kamchaisatian W; Chan LL; Koh MT; Wong KJ; Fong SM; Thong MK; Latiff ZA; Noh LM; de Silva R; Jouhadi Z; Al-Saad K; Vignesh P; Jindal AK; Rawat A; Gupta A; Suri D; Yang J; Au EY; Kwok JS; Chan SY; Hui WY; Chua GT; Duque JR; Cheong KN; Chong PCY; Ho MHK; Lee TL; Wong WH; Yang W; Lee PP; Tu W; Yang XQ; Lau YL
    Front Immunol; 2022; 13():883446. PubMed ID: 35874699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of next generation sequencing (NGS) data re-analysis in the diagnosis of monogenic diseases leading to organ failure.
    Saglia C; Bracciamà V; Trotta L; Mioli F; Faini AC; Brach Del Prever GM; Kalantari S; Luca M; Romeo CM; Scolari C; Peruzzi L; Calvo PL; Mussa A; Fenoglio R; Roccatello D; Alberti C; Carli D; Amoroso A; Deaglio S; Vaisitti T
    BMC Med Genomics; 2023 Nov; 16(1):303. PubMed ID: 38012624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of next generation sequencing in pediatric practice in Lebanon. A Study on 213 cases.
    Nair P; Sabbagh S; Mansour H; Fawaz A; Hmaimess G; Noun P; Dagher R; Megarbane H; Hana S; Alame S; Lamaa M; Hasbini D; Farah R; Rajab M; Stora S; El-Tourjuman O; Abou Jaoude P; Chalouhi G; Sayad R; Gillart AC; Al-Ali M; Delague V; El-Hayek S; Mégarbané A
    Mol Genet Genomic Med; 2018 Nov; 6(6):1041-1052. PubMed ID: 30293248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.
    Neřoldová M; Ciara E; Slatinská J; Fraňková S; Lišková P; Kotalová R; Globinovská J; Šafaříková M; Pfeiferová L; Zůnová H; Mrázová L; Stránecký V; Vrbacká A; Fabián O; Sticová E; Skanderová D; Šperl J; Kalousová M; Zima T; Macek M; Pawlowska J; Knisely AS; Kmoch S; Jirsa M
    PLoS One; 2023; 18(7):e0288907. PubMed ID: 37471416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fundoscopy-directed genetic testing to re-evaluate negative whole exome sequencing results.
    Cho A; Lima de Carvalho JR; Tanaka AJ; Jauregui R; Levi SR; Bassuk AG; Mahajan VB; Tsang SH
    Orphanet J Rare Dis; 2020 Jan; 15(1):32. PubMed ID: 32000842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.
    Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Pizzo E; Gianino MM; Damiani G
    JAMA Netw Open; 2024 Jan; 7(1):e2353514. PubMed ID: 38277144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-exome sequencing reveals ANO8 as a genetic risk factor for intrahepatic cholestasis of pregnancy.
    Liu X; Lai H; Zeng X; Xin S; Nie L; Liang Z; Wu M; Chen Y; Zheng J; Zou Y
    BMC Pregnancy Childbirth; 2020 Sep; 20(1):544. PubMed ID: 32942997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased diagnostic yield in complex dystonia through exome sequencing.
    Wirth T; Tranchant C; Drouot N; Keren B; Mignot C; Cif L; Lefaucheur R; Lion-François L; Méneret A; Gras D; Roze E; Laroche C; Burbaud P; Bannier S; Lagha-Boukbiza O; Spitz MA; Laugel V; Bereau M; Ollivier E; Nitschke P; Doummar D; Rudolf G; Anheim M; Chelly J
    Parkinsonism Relat Disord; 2020 May; 74():50-56. PubMed ID: 32334381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular diagnosis in patients with monogenic diabetes mellitus, and detection of a novel candidate gene.
    Goksen D; Evin F; Isik E; Ozen S; Atik T; Ozkinay F; Akcan N; Ozkan B; Buyukinan M; Nuri Ozbek M; Darcan S; Onay H
    Diabetes Res Clin Pract; 2023 Nov; 205():110953. PubMed ID: 37838154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of monogenic liver diseases in childhood by next-generation sequencing.
    Stalke A; Skawran B; Auber B; Illig T; Schlegelberger B; Junge N; Goldschmidt I; Leiskau C; von Neuhoff N; Baumann U; Pfister ED
    Clin Genet; 2018 Mar; 93(3):665-670. PubMed ID: 28776642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative yield of molecular diagnostic algorithms for autism spectrum disorder diagnosis in India: evidence supporting whole exome sequencing as first tier test.
    Sheth F; Shah J; Jain D; Shah S; Patel H; Patel K; Solanki DI; Iyer AS; Menghani B; Mhatre P; Mehta S; Bajaj S; Patel V; Pandya M; Dhami D; Patel D; Sheth J; Sheth H
    BMC Neurol; 2023 Aug; 23(1):292. PubMed ID: 37543562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patients.
    Cui W; Milner-Watts C; O'Sullivan H; Lyons H; Minchom A; Bhosle J; Davidson M; Yousaf N; Scott S; Faull I; Kushnir M; Nagy R; O'Brien M; Popat S
    Eur J Cancer; 2022 Aug; 171():44-54. PubMed ID: 35704974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.
    Shin H; Sa JK; Bae JS; Koo H; Jin S; Cho HJ; Choi SW; Kyoung JM; Kim JY; Seo YJ; Joung JG; Kim NKD; Son DS; Chung J; Lee T; Kong DS; Choi JW; Seol HJ; Lee JI; Suh YL; Park WY; Nam DH
    Cancer Res Treat; 2020 Jan; 52(1):41-50. PubMed ID: 31096737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.